- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04872946
Topical and Oral Regimen for Skin Health
April 29, 2021 updated by: Integrative Skin Science and Research
The overall objective of this study is to assess how oral supplementation with Inner Calm and the use of topical Super Calm can affect the appearance of skin and inner wellness, such as redness, skin sensitivity, and reactionary skin.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The landscape for skin health has expanded past a focused use of topicals to incorporate the use of supplementation.
Notable examples include the ingestion of carotenoids and beta-carotene to augment skin antioxidant status or the role of diet on different skin conditions.
The role of this investigation is to define how Inner Calm (oral supplementation) may promote healthier skin and how this may work in synergy with Super Calm (topical supplementation).
Study Type
Interventional
Enrollment (Actual)
74
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Sacramento, California, United States, 95815
- Integrative Skin Science and Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women aged 18-55
- Fitzpatrick skin type 1-4
- Self-perception as sensitive skin
Exclusion Criteria:
Exclusion Criteria:
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant or breast-feeding women
- Prisoners
- Those who have used isotretinoin in the last 6 months
- Those who have used products containing salicylic acid, beta hydroxyl acids or vitamins A, C, or E or topical retinoids or topical depigmenting agents (such as hydroquinone, kojic acid, azelaic acid, or others in opinion of the investigator) in the last 14 days
- Those who are currently smoking or have smoked within the past 3 years.
- Those who have had a recent surgical or cosmetic procedure in the last 3 months that can affect facial wrinkles, redness, or hyperpigmentation, such as botulinum toxin injections, chemical peels, laser-based therapies to the face, or face lift surgeries
- Subjects with known allergy to any of the components of Inner Calm or Skin Calm
- Those that are unwilling to discontinue use of any other nutritional supplements including antioxidants, herbs, or protein-based supplements for 2 weeks prior to and during their participation.
- Subjects with a diagnosis of acne
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: InnerCalm+skin care
An oral supplement and topical agent will be assigned.
|
Ashwagandha(Withania somnifera) root and leaf extract (32% Withania Oligosaccharides, 10% Withanolide Glycosides, 0.5% Withaferin A) 125 mg Saffron(Crocus Sativus) stigmas extract (3.48% Crocin and 0.03% Safranal) 28mg
Aqua/Water/Eau, Glycerin, Propanediol, Diheptyl Succinate, Caprylic/Capric Triglyceride, Lactococcus Ferment Lysate, Sorbitol, Dimethicone, Steareth-21, Octyldodecyl Neopentanoate, Sodium Polyacrylate, Steareth-2, Caprylyl Glycol, Hydrogenated Polydecene, Trideceth-6, Octyldodecanol, Panthenol, Sodium PCA, Azelaic Acid, Bisabolol, Capryloyl Glycerin/Sebacic Acid Copolymer, Centella Asiatica Leaf Extract, Agastache Mexicana Flower/Leaf/Stem Extract, Caprylhydroxamic Acid, Phytic Acid, Aminomethyl Propanol, Lactic Acid, Sodium Chloride, Phenoxyethanol, Sodium Benzoate.
Aqua/Water/Eau, Glycerin, Diisopropyl Dimer Dilinoleate, Coco-Caprylate, Lactococcus Ferment Lysate, Myristyl Myristate, Dimethicone, Propanediol, Behenyl Alcohol, Glyceryl Stearate SE, Potassium Cetyl Phosphate, Palmitic Acid, Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer, Myristyl Laurate, Caprylyl Glycol, Hydroxyethylcellulose, Myristic Acid, Tocopherol, Ethylhexylglycerin, Centella Asiatica Leaf Extract, Agastache Mexicana Flower/Leaf/Stem Extract, Helianthus Annuus (Sunflower) Seed Oil, Trisodium Ethylenediamine Disuccinate, Lactic Acid, Sodium Hydroxide, Sodium Phosphate, Disodium Phosphate, Sodium Chloride, t-Butyl Alcohol, Phenoxyethanol, Sodium Benzoate.
|
|
Experimental: InnerCalm only
An oral supplement will be assigned.
|
Ashwagandha(Withania somnifera) root and leaf extract (32% Withania Oligosaccharides, 10% Withanolide Glycosides, 0.5% Withaferin A) 125 mg Saffron(Crocus Sativus) stigmas extract (3.48% Crocin and 0.03% Safranal) 28mg
|
|
Experimental: Skincare Only
A topical agent only will be assigned.
|
Aqua/Water/Eau, Glycerin, Propanediol, Diheptyl Succinate, Caprylic/Capric Triglyceride, Lactococcus Ferment Lysate, Sorbitol, Dimethicone, Steareth-21, Octyldodecyl Neopentanoate, Sodium Polyacrylate, Steareth-2, Caprylyl Glycol, Hydrogenated Polydecene, Trideceth-6, Octyldodecanol, Panthenol, Sodium PCA, Azelaic Acid, Bisabolol, Capryloyl Glycerin/Sebacic Acid Copolymer, Centella Asiatica Leaf Extract, Agastache Mexicana Flower/Leaf/Stem Extract, Caprylhydroxamic Acid, Phytic Acid, Aminomethyl Propanol, Lactic Acid, Sodium Chloride, Phenoxyethanol, Sodium Benzoate.
Aqua/Water/Eau, Glycerin, Diisopropyl Dimer Dilinoleate, Coco-Caprylate, Lactococcus Ferment Lysate, Myristyl Myristate, Dimethicone, Propanediol, Behenyl Alcohol, Glyceryl Stearate SE, Potassium Cetyl Phosphate, Palmitic Acid, Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer, Myristyl Laurate, Caprylyl Glycol, Hydroxyethylcellulose, Myristic Acid, Tocopherol, Ethylhexylglycerin, Centella Asiatica Leaf Extract, Agastache Mexicana Flower/Leaf/Stem Extract, Helianthus Annuus (Sunflower) Seed Oil, Trisodium Ethylenediamine Disuccinate, Lactic Acid, Sodium Hydroxide, Sodium Phosphate, Disodium Phosphate, Sodium Chloride, t-Butyl Alcohol, Phenoxyethanol, Sodium Benzoate.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in appearance of facial redness
Time Frame: 8 weeks
|
Photographic image analysis
|
8 weeks
|
|
Changes in appearance of facial pigmentation
Time Frame: 8 weeks
|
Photographic image analysis
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in appearance of facial redness before and after treatment
Time Frame: 8 weeks
|
SkinColorCatch colorimeter RGB range: 25-246 per channel
|
8 weeks
|
|
Subjective report of skin reactivity
Time Frame: 8 weeks
|
Topical Clinical Questionnaire
|
8 weeks
|
|
Subjective report of sleep quality and quantity
Time Frame: 8 weeks
|
Pittsburg Sleep Quality Index survey (PSQI)
|
8 weeks
|
|
Subjective report of mood and energy
Time Frame: 8 weeks
|
Abbreviated Profile of Mood States Survey (POMS)
|
8 weeks
|
|
Subjective report of calmness of mind
Time Frame: 8 weeks
|
Inner and Outer Calm Questionnaire
|
8 weeks
|
|
Subjective report of calmness of skin
Time Frame: 8 weeks
|
Inner and Outer Calm Questionnaire
|
8 weeks
|
|
Changes in appearance of facial redness
Time Frame: 4 weeks
|
Photographic image analysis
|
4 weeks
|
|
Changes in appearance of facial pigmentation
Time Frame: 4 weeks
|
Photographic image analysis
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Raja K Sivamani, MD, Integrative Skin Science and Research Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 26, 2019
Primary Completion (Actual)
May 7, 2020
Study Completion (Actual)
May 7, 2020
Study Registration Dates
First Submitted
October 9, 2020
First Submitted That Met QC Criteria
April 29, 2021
First Posted (Actual)
May 5, 2021
Study Record Updates
Last Update Posted (Actual)
May 5, 2021
Last Update Submitted That Met QC Criteria
April 29, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 008 (Nahrain Medical Research Collective (NMRC))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Abnormalities
-
Enspectra HealthNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSkin Diseases | Skin Abnormalities | Skin Cancer | Skin Lesion | Skin ConditionUnited States
-
Enspectra HealthNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSkin Diseases | Skin Abnormalities | Skin Cancer | Skin Lesion | Skin ConditionUnited States
-
Hillel Yaffe Medical CenterUnknown
-
Avita MedicalBiomedical Advanced Research and Development AuthorityTerminatedSkin; DeformityUnited States
-
HealthpointTerminatedSkin AbnormalitiesUnited States
-
University of MiamiCompletedAging | Skin AbnormalitiesUnited States
-
Koç UniversityKoç University HospitalNot yet recruitingSkin Abnormalities | Pressure Injuries | Skin Failure | Biophysical Parameters of SkinTurkey (Türkiye)
-
University Hospital, AngersNot yet recruitingBody Representation | Feelings | Congenital Skin DisorderFrance
Clinical Trials on Tea
-
Sir Run Run Shaw HospitalNot yet recruitingColorectal Cancer (CRC)China
-
Providence Health & ServicesCompletedMetastatic Sarcoma | Metastatic Carcinoma | Metastatic LymphomaUnited States
-
National University of SingaporeTea Explorer Pte. Ltd.Active, not recruiting
-
University of ArizonaUnited States Department of DefenseCompletedLung Cancer Prevention
-
University of LahoreCompleted
-
IsuraCompletedSafety | Bioavailability and PharmacokineticsCanada
-
University of Missouri-ColumbiaCompletedGlucose | Blood Sugar; High | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
Northumbria UniversityFinzelbergCompletedCognitive Change | Blood Pressure | Affect | NeuroimagingUnited Kingdom
-
University of Uyo Teaching HospitalCompletedBlood Pressure | Blood Glucose | Heart RateNigeria
-
Aberystwyth UniversityTeTrimTeas CyfActive, not recruitingObesity | Well-beingUnited Kingdom